LivaNova announces FDA Warning Letter closed for Munich and Arvada facilities

LivaNova PLC

FDA issued Warning Letter in Dec 2015 over regulatory violations at two facilities.
Company completed remediation actions to address alleged violations and observations.
Received FDA communication dated Nov 28, 2022 indicating the Warning Letter is closed.
No penalty or ongoing compliance obligations detailed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.